AKUMS DRUGS AND PHARMA L (AKUMS)

NSE: ₹555.50
BSE: ₹556.10
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 317.28 328.35 337.41 328.75 332.44 309.32 368.61 338.37
YOY Revenue Growth % - - - - 4.78% -5.8% 9.25% 2.93%
Other Income 26.18 32.12 33.84 32.05 28.56 27.08 29.60 27.73
Total Income 343.45 360.47 371.25 360.80 361.00 336.39 398.21 366.10
Total Expenses + 289.18 298.85 316.36 323.75 301.49 305.19 358.54 341.60
Cost of Materials Consumed 200.90 196.47 206.62 207.06 192.55 202.31 222.67 212.81
Employee Benefit Expense 47.18 50.38 50.34 53.84 50.74 54.58 54.80 57.88
Other Expenses 37.69 44.51 38.56 49.78 42.77 46.63 54.75 62.04
Operating Profit 28.10 29.50 21.05 5.01 30.95 4.12 10.07 -3.23
OPM % 8.9% 9% 6.2% 1.5% 9.3% 1.3% 2.7% -1%
Profit Before Tax + 54.27 61.62 54.89 37.06 59.51 31.20 35.87 21.79
Tax Expense 12.40 11.25 13.72 9.47 14.64 7.74 7.75 6.59
Tax % 22.8% 18.3% 25% 25.5% 24.6% 24.8% 21.6% 30.3%
Profit After Tax 41.88 50.37 41.17 27.59 44.87 23.46 28.11 15.20
EPS (Basic) 2.93 3.38 2.69 1.80 2.93 1.53 1.84 0.99

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 1,348.74 1,311.78
YOY Revenue Growth % 2.82% -
Other Income 112.97 124.19
Total Income 1,461.70 1,435.98
Total Expenses + 1,306.82 1,228.14
Cost of Materials Consumed 830.34 811.06
Employee Benefit Expense 217.99 201.74
Other Expenses 206.20 170.54
Operating Profit 41.92 83.65
OPM % 3.1% 6.4%
Profit Before Exceptional 154.88 207.84
Exceptional Items -6.52 0.00
Profit Before Tax + 148.37 207.84
Tax Expense 36.73 46.84
Tax % 24.8% 22.5%
Profit After Tax 111.64 161.00
EPS (Basic) 7.29 10.76

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 1,488.98 1,851.73
Property, Plant & Equipment 403.53 334.92
Capital Work in Progress 51.57 53.71
Non-Current Investments 366.02 0.00
Goodwill 0.00 0.00
Other Intangible Assets 3.40 2.60
Current Assets + 1,323.50 833.18
Inventories 229.93 201.69
Trade Receivables 217.54 206.14
Cash and Cash Equivalents 46.38 76.49
Current Investments 0.00 0.00
LIABILITIES & EQUITY
Total Equity 2,427.57 2,305.25
Equity Share Capital 30.62 30.62
Other Equity 2,396.95 2,274.63
Non-Current Liabilities 80.92 70.36
Current Liabilities 304.00 309.31
Total Liabilities 384.91 379.66

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities -1.99 91.00
Cash from Investing Activities -24.97 -458.84
Cash from Financing Activities -3.15 375.38
Net Increase/Decrease in Cash -30.11 7.54